Two DMT dosing studies hit participant withdrawals at the high end.
CYB004, a deuterated DMT built for a steadier profile, was only acceptably tolerated at plasma concentrations matching plain DMT; a separate intravenous DMT study had two subjects stop their infusion for anxiety. A 20-person crossover compared whole-mushroom oral psilocybin, oral psilocin and sublingual psilocin.